| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3340352 | Allergologia et Immunopathologia | 2008 | 5 Pages |
Abstract
Although recombinant allergens can be produced for in vitro diagnostic purposes, current legislation only allows the use of natural proteins for immunotherapy. However, the same technology can be applied to the study of extracts for vaccines, and it seems that allergen quantification by the manufacturers is a no return trip which clinicians are obliged to follow.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
C. Moreno-Aguilar,